The expression of mRNA for a kappa opioid receptor in the substantia nigra of Parkinson's disease brain

Mitsuhiko Yamada, Karen Groshan, Chan Tran Phung, Misa Yamada, Takashi Hisamitsu, Elliott Richelson

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

We molecularly cloned the kappa opioid receptor from a human substantia nigra cDNA library. When expressed in HEK293 cells, the cloned receptor had similar pharmacological characteristics to the rat kappa opioid receptor. Northern blot analysis showed the presence of a single transcript of about 6 kb in size for mRNA prepared from the substantia nigra. Using in situ hybridization histochemistry, we studied the expression of this receptor in postmortem human brains from control and Parkinson's disease subjects. Kappa opioid receptor mRNA was present in melanized (possibly dopaminergic) neurons of the substantia nigra and the nucleus paranigralis. On the other hand, Parkinson's disease brains had markedly fewer melanized neurons, as expected, and correspondingly very low or background levels of mRNA for the kappa opioid receptor. However, in some cases, remaining melanized neurons still expressed the receptor mRNA. From these results we suggest that dopaminergic neurons in the human substantia nigra and the nucleus paranigralis synthesize kappa opioid receptors and express them in their perikarya and their terminal regions. The kappa opioid receptor expressed in the melanized neurons may play a role in the normal function of dopaminergic systems and possibly in the etiology of Parkinson's disease.

Original languageEnglish (US)
Pages (from-to)12-20
Number of pages9
JournalMolecular Brain Research
Volume44
Issue number1
DOIs
StatePublished - Feb 1997

Fingerprint

kappa Opioid Receptor
Substantia Nigra
Parkinson Disease
Messenger RNA
Brain
Dopaminergic Neurons
Neurons
HEK293 Cells
Brain Diseases
Gene Library
Northern Blotting
In Situ Hybridization
Pharmacology

Keywords

  • Aging
  • Dopamine
  • Human
  • Melanin
  • Molecular cloning
  • Transfection

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

The expression of mRNA for a kappa opioid receptor in the substantia nigra of Parkinson's disease brain. / Yamada, Mitsuhiko; Groshan, Karen; Phung, Chan Tran; Yamada, Misa; Hisamitsu, Takashi; Richelson, Elliott.

In: Molecular Brain Research, Vol. 44, No. 1, 02.1997, p. 12-20.

Research output: Contribution to journalArticle

Yamada, Mitsuhiko ; Groshan, Karen ; Phung, Chan Tran ; Yamada, Misa ; Hisamitsu, Takashi ; Richelson, Elliott. / The expression of mRNA for a kappa opioid receptor in the substantia nigra of Parkinson's disease brain. In: Molecular Brain Research. 1997 ; Vol. 44, No. 1. pp. 12-20.
@article{7c8d5fb13d114b0ea0cdca0985653680,
title = "The expression of mRNA for a kappa opioid receptor in the substantia nigra of Parkinson's disease brain",
abstract = "We molecularly cloned the kappa opioid receptor from a human substantia nigra cDNA library. When expressed in HEK293 cells, the cloned receptor had similar pharmacological characteristics to the rat kappa opioid receptor. Northern blot analysis showed the presence of a single transcript of about 6 kb in size for mRNA prepared from the substantia nigra. Using in situ hybridization histochemistry, we studied the expression of this receptor in postmortem human brains from control and Parkinson's disease subjects. Kappa opioid receptor mRNA was present in melanized (possibly dopaminergic) neurons of the substantia nigra and the nucleus paranigralis. On the other hand, Parkinson's disease brains had markedly fewer melanized neurons, as expected, and correspondingly very low or background levels of mRNA for the kappa opioid receptor. However, in some cases, remaining melanized neurons still expressed the receptor mRNA. From these results we suggest that dopaminergic neurons in the human substantia nigra and the nucleus paranigralis synthesize kappa opioid receptors and express them in their perikarya and their terminal regions. The kappa opioid receptor expressed in the melanized neurons may play a role in the normal function of dopaminergic systems and possibly in the etiology of Parkinson's disease.",
keywords = "Aging, Dopamine, Human, Melanin, Molecular cloning, Transfection",
author = "Mitsuhiko Yamada and Karen Groshan and Phung, {Chan Tran} and Misa Yamada and Takashi Hisamitsu and Elliott Richelson",
year = "1997",
month = "2",
doi = "10.1016/S0169-328X(96)00139-8",
language = "English (US)",
volume = "44",
pages = "12--20",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - The expression of mRNA for a kappa opioid receptor in the substantia nigra of Parkinson's disease brain

AU - Yamada, Mitsuhiko

AU - Groshan, Karen

AU - Phung, Chan Tran

AU - Yamada, Misa

AU - Hisamitsu, Takashi

AU - Richelson, Elliott

PY - 1997/2

Y1 - 1997/2

N2 - We molecularly cloned the kappa opioid receptor from a human substantia nigra cDNA library. When expressed in HEK293 cells, the cloned receptor had similar pharmacological characteristics to the rat kappa opioid receptor. Northern blot analysis showed the presence of a single transcript of about 6 kb in size for mRNA prepared from the substantia nigra. Using in situ hybridization histochemistry, we studied the expression of this receptor in postmortem human brains from control and Parkinson's disease subjects. Kappa opioid receptor mRNA was present in melanized (possibly dopaminergic) neurons of the substantia nigra and the nucleus paranigralis. On the other hand, Parkinson's disease brains had markedly fewer melanized neurons, as expected, and correspondingly very low or background levels of mRNA for the kappa opioid receptor. However, in some cases, remaining melanized neurons still expressed the receptor mRNA. From these results we suggest that dopaminergic neurons in the human substantia nigra and the nucleus paranigralis synthesize kappa opioid receptors and express them in their perikarya and their terminal regions. The kappa opioid receptor expressed in the melanized neurons may play a role in the normal function of dopaminergic systems and possibly in the etiology of Parkinson's disease.

AB - We molecularly cloned the kappa opioid receptor from a human substantia nigra cDNA library. When expressed in HEK293 cells, the cloned receptor had similar pharmacological characteristics to the rat kappa opioid receptor. Northern blot analysis showed the presence of a single transcript of about 6 kb in size for mRNA prepared from the substantia nigra. Using in situ hybridization histochemistry, we studied the expression of this receptor in postmortem human brains from control and Parkinson's disease subjects. Kappa opioid receptor mRNA was present in melanized (possibly dopaminergic) neurons of the substantia nigra and the nucleus paranigralis. On the other hand, Parkinson's disease brains had markedly fewer melanized neurons, as expected, and correspondingly very low or background levels of mRNA for the kappa opioid receptor. However, in some cases, remaining melanized neurons still expressed the receptor mRNA. From these results we suggest that dopaminergic neurons in the human substantia nigra and the nucleus paranigralis synthesize kappa opioid receptors and express them in their perikarya and their terminal regions. The kappa opioid receptor expressed in the melanized neurons may play a role in the normal function of dopaminergic systems and possibly in the etiology of Parkinson's disease.

KW - Aging

KW - Dopamine

KW - Human

KW - Melanin

KW - Molecular cloning

KW - Transfection

UR - http://www.scopus.com/inward/record.url?scp=0031027713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031027713&partnerID=8YFLogxK

U2 - 10.1016/S0169-328X(96)00139-8

DO - 10.1016/S0169-328X(96)00139-8

M3 - Article

VL - 44

SP - 12

EP - 20

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -